Founded a technology development incubator to identify, evaluate, fund, develop, commercialize and manage early stage research at universities, medical schools and small businesses.

Founder, CEO and Director of a development stage, publicly traded biotechnology company, to commercialize cancer diagnostic, prognostic and therapeutic technologies.Successfully implemented sponsored research agreements at the Allegheny-Singer Research Institute (ASRI) of West Penn Health System (Pittsburgh, PA). Executed worldwide exclusive licensing agreements with ASRI, Columbia University (New York, NY) and the Institut Gustave Roussy (Paris, France) resulting in the acquisition of intellectual property including patents and monoclonal antibodies for the diagnosis, prognosis and treatment of virtually all forms of cancer. Established collaborations with the John Wayne Cancer Institute (Santa Monica, CA), Biomedical Research Foundation of Northwest Louisiana (Shreveport, LA), CytoGenix Corp. (Houston, TX), The CanSolve Cancer Foundation (Houston, TX), faculty of the University of Texas, M.D. Anderson Cancer Center (Houston, TX) and Arkios BioDevelopment International (Virginia Beach, VA). Successfully oversaw the transition of Omnimmune Corp. from a closely held private company into a publicly traded company in August, 2008.

Positioned, developed and lead Spectrix Analytical Division (previously Spectrix Corp. prior to acquisition by Keystone) to become the flagship laboratory of a national network of environmental testing laboratories.Established highly sophisticated, national network of environmental testing laboratories for Keystone based on state-of-the-art analytical chemistry and information technology Trained at 3M Corporation to become a certified Facilitator in a Total Quality Management program for Keystone.

Established and lead one of the first consulting analytical chemistry testing laboratories in the United States based on gas chromatography-mass spectrometry (GC-MS).Developed Spectrix into an elite and one of the first of an original group of twenty-five EPA Superfund qualified laboratories. Successfully educated industries in the value and integration of GC-MS with a wide range of analytical technologies to provide comprehensive services in the fields of biomedicine, occupational health, pharmaceuticals, petroleum, petrochemistry, toxicology, engineering and environment. Positioned Spectrix for sale to Keystone Environmental Services, Inc., a subsidiary of Koppers Inc., a Fortune 500 company, in a multimillion dollar transaction.